Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
11.03. | Gilead launches patient hub to 'expose' realities of living with metastatic breast cancer | ||
11.03. | Incyte's JAK cream Opzelura proves its worth in treating hidradenitis suppurativa in midstage study | ||
11.03. | Legend CEO offers preview of high-stakes FDA adcomm for J&J-partnered Carvykti | ||
11.03. | Viatris' launch plans scuttled as FDA rebuffs long-acting MS drug from partner Mapi | ||
11.03. | Eli Lilly, with Oscars in its sights, calls out stars who use GLP-1 drugs to fit in a dress or tux | ||
11.03. | Bluebird bio inks first Medicaid coverage agreement for sickle cell gene therapy, signing on with Michigan | ||
11.03. | Sun Pharma issues recall of gout drug due to microbial contamination | ||
08.03. | Novo's obesity superstar Wegovy wins FDA nod to cut cardio risks in key label expansion | ||
08.03. | Exact Sciences gets in on the March Madness, drafting former pro Mashburn for colon cancer awareness campaign | ||
08.03. | GSK, facing Shingrix penetration plateau, doubles funding for adult vaccine uptake programs | ||
08.03. | After trial failure, will Amylyx pull ALS drug Relyvrio off the market? | ||
08.03. | Bristol Myers, overshadowed by ADC rival, wins FDA nod for Opdivo combo in bladder cancer | ||
08.03. | PhRMA seeks to revive Medicare price negotiations lawsuit, blasts Biden's request for IRA expansion | ||
07.03. | Eli Lilly flags bacteria, impurity concerns in fake and compounded versions of popular GLP-1 meds | ||
07.03. | Despite pharma growth, Merck KGaA's CDMO slowdown plays into company's overall sales decline | ||
07.03. | Despite Leqembi's launch pains, Eisai projects Alzheimer's med will reach $8.8B in the long run | ||
07.03. | Boehringer Ingelheim cuts monthly out-of-pocket inhaler prices to $35 for US patients | ||
07.03. | After withdrawal, GSK touts another Blenrep combo win as analysts build blockbuster case for the myeloma ADC | ||
07.03. | UCB ups the ante with CDMO Samsung Biologics, signing $353M deal | ||
06.03. | Not-so-dirty words: Dr. Pimple Popper appears in another Sun Pharma ad to open up acne talk | ||
06.03. | WHO flags increasing resistance to GSK's HIV med Tivicay in some countries | ||
06.03. | Growing Almac boosts capacity for manufacturing peptides and packaging commercial products | ||
06.03. | AstraZeneca pledges £650M in UK investments to boost vaccine capabilities, expand near HQ | ||
06.03. | Argonaut's journey continues with $45M in new financing for facility expansion | ||
06.03. | Everlywell flushes away 'stool stigma' to bump up at-home colon cancer screening rates |